These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22830601)

  • 1. Systemic steroids in the treatment of psoriasis: what is fact, what is fiction?
    Mrowietz U; Domm S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1022-5. PubMed ID: 22830601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatment with corticosteroids in psoriasis--health care provision far beyond the S3-guidelines.
    Augustin M; Schäfer I; Reich K; Glaeske G; Radtke M
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):833-8. PubMed ID: 21627773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases.
    Semble AL; Davis SA; Feldman SR
    Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug supply for children with psoriasis in Germany.
    Augustin M; Reich K; Glaeske G; Kämpfe S; Radtke MA; Gerdau-Heitmann C; Schicktanz C; Schäfer I
    J Dtsch Dermatol Ges; 2013 Aug; 11(8):751-5. PubMed ID: 23718227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study.
    Kresch M; Weingarten M; Guenin S; Wei N; Elbogen E; Correa da Rosa J; Lebwohl M
    J Am Acad Dermatol; 2023 May; 88(5):1182-1183. PubMed ID: 36538947
    [No Abstract]   [Full Text] [Related]  

  • 7. Home ultraviolet B phototherapy for psoriasis: discrepancy between literature, guidelines, general opinions and actual use. Results of a literature review, a web search, and a questionnaire among dermatologists.
    Koek MB; Buskens E; Bruijnzeel-Koomen CA; Sigurdsson V
    Br J Dermatol; 2006 Apr; 154(4):701-11. PubMed ID: 16536814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
    Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized pustular psoriasis of pregnancy treated with narrowband UVB and topical steroids.
    Vun YY; Jones B; Al-Mudhaffer M; Egan C
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S28-30. PubMed ID: 16427987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis.
    Gregoire ARF; DeRuyter BK; Stratman EJ
    JAMA Dermatol; 2021 Feb; 157(2):198-201. PubMed ID: 33206132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing use of more potent treatments for psoriasis.
    Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis treatment in the United States at the end of the 20th century.
    Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
    Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes in patients with psoriasis.
    Tidman MJ
    Practitioner; 2013 Jan; 257(1757):27-30, 3. PubMed ID: 23469725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital].
    Adnot-Desanlis L; Brochot P; Eschard JP; Bernard P; Reguiaï Z
    Ann Dermatol Venereol; 2012 May; 139(5):355-62. PubMed ID: 22578339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate to severe psoriasis: from topical to biological treatment.
    Gardinal I; Ammoury A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1324-6. PubMed ID: 19470061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity and smoking on psoriasis presentation and management.
    Herron MD; Hinckley M; Hoffman MS; Papenfuss J; Hansen CB; Callis KP; Krueger GG
    Arch Dermatol; 2005 Dec; 141(12):1527-34. PubMed ID: 16365253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis.
    Weigle N; McBane S
    Am Fam Physician; 2013 May; 87(9):626-33. PubMed ID: 23668525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
    J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and intraocular inflammation.
    Knox DL
    Trans Am Ophthalmol Soc; 1979; 77():210-24. PubMed ID: 575684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.